A phase III placebo- and oxycodone-controlled study of tanezumab in adults with osteoarthritis pain of the hip or knee: response

Pain. 2014 Nov;155(11):2432-2433. doi: 10.1016/j.pain.2014.08.038. Epub 2014 Sep 3.

Authors

Egilius L H Spierings¹, James Fidelholtz, Gernot Wolfram, Michael D Smith, Mark T Brown, Christine R West

Affiliation

¹ Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA Hilltop Physicians Inc., Cincinnati, OH, USA Pfizer Inc., Groton, CT, USA.

PMID: 25194672
DOI: 10.1016/j.pain.2014.08.038

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use*
Female
Humans
Male
Narcotics / therapeutic use*
Oxycodone / therapeutic use*
Pain / drug therapy*

Substances

Antibodies, Monoclonal, Humanized
Narcotics
Oxycodone